PVLA Pieris Pharma Total Asset Value of Company
The price indicator on the total assets chart for Pieris Pharmaceuticals (PVLA), with a value of 163.66, reflects the dynamics of a company implementing eco-friendly closed-loop water consumption cycles. The business relies on unique Anticalin proteins to combat fibrosis and oncology, ensuring significant pricing power. However, the firm is currently undergoing a painful restructuring due to the failure of several clinical trials, which calls into question the preservation of capital.
Analytical breakdowns and data insights for company Pieris Pharmaceuticals Inc (PVLA)
- market value and analyst target forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Pieris Pharmaceuticals|PVLA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Pieris Corp|PVLA - Company Aggregate Debts|Debts to Book Capitalization Pieris Corp|PVLA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Pieris Pharmaceuticals|Interim Coverage Ratio pieris.com
- net income and valuation multiples indicators:
Fundamental valuation:Pieris Pharmaceuticals
Long-term investing requires strict control over the gap between market capitalization and a company's actual assets. For Pieris Pharmaceuticals (PVLA), which lacks revenue and depends on external financing, an analysis of consolidated assets calculated reversely via ROA is critical: it reveals a dangerous degradation of resources against a backdrop of speculative price spikes, signaling a high risk of a sharp correction in the share price.
Key competitors
argenx.com (ARGX) - Company Total Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Savara Inc (SVRA) - Company Assets|RIGL - Aggregate Company Assets|Total Asset Value of Company ANAB|ATXS: Company Total Assets|ENGN - Company Total Asset Base|RAPT (RAPT Therapeutics) - Company Total Assets|Company Assets Aerovate JBIO|Aggregate Company Assets Aclaris (ACRS)|KYTX (Kyverna Therapeutics, Inc) - Aggregate Asset Value|Company Total Assets TLSA (Tiziana Life Sciences)|Company Total Asset Base cabalettabio.com (CABA)|VTYX - Aggregate Company Assets|Company Total Asset Base Theratechnologies, Inc. THTX|AVTX (Avalo Therapeutics Inc.) - Cumulative Company Assets|Eledon Pharmaceuticals, Inc - Aggregate Asset Value|Aggregate Company Assets Agenus|climbbio.com - Total Asset Value of Company|Company Total Assets ZURA|ATYR (aTyr Pharma Inc) - Aggregate Asset Value|Company Total Assets ADAG (Adagene Inc.)|Company Total Assets ImageneBio IMA|STTK - Aggregate Company Assets|Aggregate Asset Value EQ (Equillium, Inc.)|connectbiopharm.com (CNTB) - Aggregate Company Assets|Cumulative Company Assets Immunic|ATRA (Atara Biotherapeutics, Inc.) - Company Total Assets|Company Total Assets InflaRx GmbH|Company Total Assets XFOR|Cumulative Company Assets adicetbio.com ACET|Company Total Assets CELU (Celularity)|INmune Bio Inc (INMB) - Company Assets|BRNS: Cumulative Company Assets|KZR - Company Total Assets|SABS (SAB Biotherapeutics) - Cumulative Company Assets|AKTX: Aggregate Business Assets|ENLV (Enlivex Therapeutics Ltd) - Company Total Assets|Q32 Bio Corp (QTTB) - Company Total Asset Base|Company Total Assets GOVX|Cumulative Company Assets Edesa Biotech Corp EDSA|Company Total Assets IBIO (iBio, Inc.)|Company Total Assets Carisma Therapeutics Inc CARM|XTLB - Aggregate Company Assets|BOLT: Aggregate Company Assets|hcwbiologics.com (HCWB) - Aggregate Company Assets|APVO - Company Total Asset Base|Aggregate Company Assets AIM ImmunoTech Inc.|Aditxt Corp - Total Asset Value of Company|Cumulative Company Assets GRI (GRI Bio)|Aggregate Company Assets XRTX (XORTX Therapeutics Inc)|Aggregate Company Assets ReShape Lifesciences HIND|Revelation Biosciences Corp - Aggregate Company Assets|Indaptus Therapeutics - Company Total Assets|SCNI - Company Total Assets|calcimedica.com (CALI) - Aggregate Company Assets|Total Asset Value of Company AFMD (Affimed N.V.)|ALLK (Allakos Inc) - Company Total Assets|HOOK: Aggregate Asset Value|Company Total Assets IGMS|Company Total Assets iteostherapeutics.com (ITOS)|Aggregate Company Assets Ocean Biomedical OCEA|Aggregate Asset Value TCBP|THRD - Aggregate Company Assets